OraSure Technologies: Carrie Eglinton Manner, Nancy Gagliano, Kathleen Weber
OraSure Technologies has appointed Carrie Eglinton Manner to the role of president and CEO, replacing interim CEO Nancy Gagliano, according to a filing with US Securities and Exchange Commission. Prior to joining OraSure, Eglinton Manner served as senior VP, advanced and general diagnostic and clinical solutions at Quest Diagnostics since January 2017. Prior to Quest, she served in various leadership roles at GE Healthcare, including as president and CEO of four distinct GE Healthcare global businesses in the areas of diagnostic imaging, lab services, and medical devices.
In connection with Eglinton Manner's appointment, Gagliano will resign from her position on June 4.
In addition, Kathleen Weber, OraSure's president of molecular solutions, has also informed the company that she will resign. Pursuant to the terms of her employment, her resignation is planned for Aug. 21, 2022.